Education
About Us
Working with TipRanks
Follow Us
DarioHealth Corp (DRIO)
NASDAQ:DRIO
DRIO Stock Chart & Stats
$10.04
-$0.63(-41.18%)
At close: 4:00 PM EST
$10.04
-$0.63(-41.18%)
Day’s Range― - ―
52-Week Range$5.94 - $31.00
Previous CloseN/A
Volume780.96K
Average Volume (3M)33.32K
Market Cap
$67.95M
Enterprise Value$53.96M
Total Cash (Recent Filing)$32.13M
Total Debt (Recent Filing)$31.64M
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Mar 24, 2026EPS Estimate
-3.79Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.96
Shares Outstanding6,768,184
10 Day Avg. Volume41,359
30 Day Avg. Volume33,324
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)14.66
Price to Sales (P/S)39.06
P/FCF Ratio-27.29
Enterprise Value/Market Cap0.79
Enterprise Value/Revenue2.18
Enterprise Value/Gross Profit3.42
Enterprise Value/Ebitda-1.60
Forecast
1Y Price Target
$13.50Price Target Upside34.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Client AcquisitionThe company noted two new major health plan clients, with one scheduled to launch in the second half of 2025, bringing their total clients signed year-to-date to 21.
Financial ManagementEncouraged by management's ability to lower expenses and continue to sign meaningful new customer.
Growth OpportunitiesManagement quantified their pipeline at $53 million, with $5 million being in an advanced stage, indicating potential growth opportunities.
Bears Say
Contract RenewalA significant contract expiration contributed to the revenue miss and is pending renewal.
Guidance AdjustmentDarioHealth subsequently cut its breakeven cash flow guidance from the end of 2025 to the end of 2026 or early 2027.
Revenue ChallengesThe 2Q headline numbers were disappointing, with revenue and EBITDA coming in substantially below estimates.
DarioHealth News
DRIO FAQ
What was DarioHealth Corp’s price range in the past 12 months?
DarioHealth Corp lowest stock price was $5.93 and its highest was $31.00 in the past 12 months.
What is DarioHealth Corp’s market cap?
DarioHealth Corp’s market cap is $67.95M.
When is DarioHealth Corp’s upcoming earnings report date?
DarioHealth Corp’s upcoming earnings report date is Mar 24, 2026 which is in 86 days.
How were DarioHealth Corp’s earnings last quarter?
DarioHealth Corp released its earnings results on Nov 13, 2025. The company reported -$2.96 earnings per share for the quarter, beating the consensus estimate of -$4.9 by $1.94.
Is DarioHealth Corp overvalued?
According to Wall Street analysts DarioHealth Corp’s price is currently Undervalued.
Does DarioHealth Corp pay dividends?
DarioHealth Corp does not currently pay dividends.
What is DarioHealth Corp’s EPS estimate?
DarioHealth Corp’s EPS estimate is -3.79.
How many shares outstanding does DarioHealth Corp have?
DarioHealth Corp has 6,768,184 shares outstanding.
What happened to DarioHealth Corp’s price movement after its last earnings report?
DarioHealth Corp reported an EPS of -$2.96 in its last earnings report, beating expectations of -$4.9. Following the earnings report the stock price went down -15.574%.
Which hedge fund is a major shareholder of DarioHealth Corp?
Currently, no hedge funds are holding shares in DRIO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DarioHealth Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.50 (34.46% Upside)
$13.50 (34.46% Upside)
Hedge Fund Trend
Decreased
By 15.7K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-23.65%
12-Months-Change
Fundamentals
Return on Equity
-42.73%
Trailing 12-Months
Asset Growth
7.07%
Trailing 12-Months
Company Description
DarioHealth Corp
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
DRIO Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented an optimistic outlook for DarioHealth, highlighting significant client growth, cost reductions, and strong gross margins. Although there was a decline in revenue due to strategic shifts, the company's transition towards recurring revenue and high client retention suggest a positive future trajectory.View all DRIO earnings summariesDRIO Stock 12 Month Forecast
Average Price Target
$13.50
▲(34.46% Upside)
Technical Analysis
Ownership Overview
9.56% Insiders
0.51% Mutual Funds
9.17% Other Institutional Investors
80.51% Public Companies and
Individual Investors